Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2026/03/17
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market
see more
2025/01/09
Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia
see more
2024/12/19
Expert conference on Strengthening Prevention and Control of Hand, Foot, and Mouth Disease in Vietnam
see more
2024/05/10
Medigen Announces Successful Implementation of TGA GMP Standards
see more
2023/08/29
MVC partners with the WHO C-TAP Initiative as The First Private Manufacturer to Out-License COVID-19 Vaccine Technology and Know-How, Advancing Global Access to Vaccination
see more
2023/05/24
Medigen files New Drug Application for its Enterovirus 71 (EV-71) vaccine in Vietnam
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree